Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia

Detalles Bibliográficos
Autores principales: Fodstad, Philip, Dheyauldeen, Sinan, Rinde, Marit, Bachmann-Harildstad, Gregor
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070877/
https://www.ncbi.nlm.nih.gov/pubmed/20824275
http://dx.doi.org/10.1007/s00277-010-1063-5
_version_ 1782201420897845248
author Fodstad, Philip
Dheyauldeen, Sinan
Rinde, Marit
Bachmann-Harildstad, Gregor
author_facet Fodstad, Philip
Dheyauldeen, Sinan
Rinde, Marit
Bachmann-Harildstad, Gregor
author_sort Fodstad, Philip
collection PubMed
description
format Text
id pubmed-3070877
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30708772011-05-02 Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia Fodstad, Philip Dheyauldeen, Sinan Rinde, Marit Bachmann-Harildstad, Gregor Ann Hematol Letter to the Editor Springer-Verlag 2010-09-08 2011 /pmc/articles/PMC3070877/ /pubmed/20824275 http://dx.doi.org/10.1007/s00277-010-1063-5 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter to the Editor
Fodstad, Philip
Dheyauldeen, Sinan
Rinde, Marit
Bachmann-Harildstad, Gregor
Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
title Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
title_full Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
title_fullStr Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
title_full_unstemmed Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
title_short Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
title_sort anti-vegf with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070877/
https://www.ncbi.nlm.nih.gov/pubmed/20824275
http://dx.doi.org/10.1007/s00277-010-1063-5
work_keys_str_mv AT fodstadphilip antivegfwith3weekintervalsiseffectiveonanemiainapatientwithseverehereditaryhemorrhagictelangiectasia
AT dheyauldeensinan antivegfwith3weekintervalsiseffectiveonanemiainapatientwithseverehereditaryhemorrhagictelangiectasia
AT rindemarit antivegfwith3weekintervalsiseffectiveonanemiainapatientwithseverehereditaryhemorrhagictelangiectasia
AT bachmannharildstadgregor antivegfwith3weekintervalsiseffectiveonanemiainapatientwithseverehereditaryhemorrhagictelangiectasia

Ejemplares similares